Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gary M Winer Insider Profile
4 Followers
Gary M Winer, Director at LENSAR, holds 80.84K shares in LENSAR (Ticker: LNSR), holds 17.00K shares in HCW Biologics (Ticker: HCWB). Most recently, Gary M Winer Bought ― shares of LENSAR on Sep 06, 2024 for an estimated value of 3.08K.
Profitable Transactions
9 out of 18 Profitable Transactions
Average Return
+36.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Gary M Winer
Gary M Winer's Trading History
LENSAR
Sep 06, 2024
Director
Informative Buy
3.08K
$596.60K
HCW Biologics
Sep 15, 2023
Director
Informative Buy
3.26K
$13.09K
List of latest transactions for each holding click on a transaction to see Gary M Winer's performance on stock
You May Also Like
Gary M Winer insider profile FAQ
What is the percentage of profitable transactions made by Gary M Winer?
The percentage of profitable transactions made by Gary M Winer is 50%.
What is the average return per transaction made by Gary M Winer?
The average return per transaction made by Gary M Winer is 36.60%.
What stocks does Gary M Winer hold?
Gary M Winer holds: LNSR, HCWB stocks.
What was Gary M Winer’s latest transaction?
Gary M Winer latest transaction was an Informative Buy of $3.08K.
What was Gary M Winer's most profitable transaction?
Gary M Winer’s most profitable transaction was an Informative Buy of LNSR stock on November 17, 2023. The return on the trade was 236.90%.
What is Gary M Winer's role in LENSAR?
Gary M Winer's role in LENSAR is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.